scispace - formally typeset
H

Hyun Jeong Kim

Researcher at Seoul National University

Publications -  259
Citations -  3299

Hyun Jeong Kim is an academic researcher from Seoul National University. The author has contributed to research in topics: Sedation & Medicine. The author has an hindex of 26, co-authored 241 publications receiving 2714 citations. Previous affiliations of Hyun Jeong Kim include Seoul National University Bundang Hospital & New Generation University College.

Papers
More filters
Journal ArticleDOI

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer.

TL;DR: It was shown that EGFR mutation was a rare event, but high EGFR copy number was relatively frequent and correlated with EGFR overexpression in triple-negative breast cancer, suggesting that evaluation of EGFR Copy number may be useful for predicting outcomes in patients with triple- negative breast cancer and for selecting patients for anti-EGFR-targeted therapy.
Journal ArticleDOI

Development of 3-D nanofibrous fibroin scaffold with high porosity by electrospinning: implications for bone regeneration

TL;DR: Newly developed 3-D electrospun NFS may be a good candidate for use in bone regeneration andWestern immunoblotting for activated paxillin, FAK, AKT, C-Src, and ERK1/2 antibodies showed signals from the extracellular matrix were significantly increased in3-D NFS.
Journal ArticleDOI

Network Properties in Transitions of Consciousness during Propofol-induced Sedation.

TL;DR: Network changes using graph theoretical analysis of high-density EEG during patient-titrated propofol-induced sedation provide novel insights into the neural correlates of these behavioural transitions and EEG signatures for monitoring the levels of consciousness under sedation.
Journal ArticleDOI

MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer

TL;DR: In conclusion, overexpression of miR-9 is found in tumors with aggressive phenotypes and is associated with poor prognosis in breast cancer, suggesting that it may serve as a potential biomarker for breast cancer progression and a target for treatment.
Journal ArticleDOI

Effects of Botulinum Toxin Type A on Bilateral Masseteric Hypertrophy Evaluated With Computed Tomographic Measurement

TL;DR: Botulinum toxin injections are a noninvasive alternative method for treating masseteric hypertrophy and aesthetically good results with a grade of good or excellent at 12 weeks after treatment are shown.